URGN
UroGen Pharma Ltd. - Ordinary Shares (URGN)
$20
About UroGen Pharma Ltd. - Ordinary Shares (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$44.00
Daily low
$42.53
Price at open
$44.00
52 Week High
$50.81
52 Week Low
$15.86
Market cap
2.1B
Dividend yield
-
Volume
482,487
Avg. volume
696,540
P/E ratio
-21.69
UroGen Pharma Ltd. - Ordinary Shares News
Details
Daily high
$44.00
Daily low
$42.53
Price at open
$44.00
52 Week High
$50.81
52 Week Low
$15.86
Market cap
2.1B
Dividend yield
-
Volume
482,487
Avg. volume
696,540
P/E ratio
-21.69